Investor Summary
Fund Strategy
FUND PERFORMANCE AS OF 31st December 2025
| ANNUALIZED SINCE INCEPTION | QUARTERLY | YTD |
|---|---|---|
| - | - | - |
| ANNUALIZED SINCE INCEPTION | QUARTERLY | YTD |
|---|---|---|
| - | - | - |
The Voya MI Dynamic Small Cap Fund employs a quantitative machine learning approach to identify high-quality US small cap companies with sustainable growth trends. The fund underperformed the Russell 2000 Index in 4Q25 primarily due to negative stock selection in communication services, information technology, and financials sectors, along with overweight positions in utilities and information technology. Key detractors included underweight positions in Bloom Energy and overweight positions in Hudson Pacific Properties and GEO Group. Conversely, the fund benefited from strong selection in industrials, utilities, and healthcare, with notable contributors including Flowserve Corp, Amicus Therapeutics, and Fortrea Holdings. Looking ahead, the managers expect the US economy to enter 2026 with resilience, supported by moderate growth and productivity gains. However, they maintain caution regarding geopolitical risks and policy uncertainty. The broadening of market leadership beyond mega-cap growth, driven by AI innovation and sustained corporate capital expenditure, should create opportunities for nimble positioning in defensives and rate-sensitive sectors.
The fund employs a quantitative machine learning approach to identify high-quality US small cap companies with sustainable growth trends, focusing on companies that rank favorably across valuation, quality, and momentum factors while navigating a market environment where leadership is broadening beyond mega-cap growth.
The U.S. economy enters 2026 with a foundation of resilience, expecting moderate growth supported by consumer spending and productivity gains. While the outlook suggests a soft landing with moderate growth and gradual disinflation, caution is warranted as geopolitical risks and policy uncertainty persist. Broadening of market leadership beyond mega-cap growth, underpinned by AI innovation and corporate investment, should support market growth.
| Date | Letter | Tickers | Keywords | Pitches | Quick Takes |
|---|---|---|---|---|---|
| Jan 27 2026 | 2025 Q4 | BE, FLS, FOLD, FTRE, GEO, HPP | AI, Biotechnology, healthcare, industrials, real estate, small caps, technology |
BE HPP GEO FLS FOLD FTRE |
AI remained a dominant theme with strong headlines around innovation and elevated capital investment by major technology firms. Increased spending on AI infrastructure and adoption trends reinforced optimism about its role as a key driver of future growth. AI-driven innovation is supporting the broadening of market leadership beyond mega-cap growth. The fund focuses on US Small Cap Core equity strategy with broader market participation persisting, where small caps and cyclicals contributed to market performance. Market leadership is widening beyond mega-cap growth, creating opportunities in the small cap space. The fund held positions in commercial stage biotechnology companies focused on rare disease therapies. Amicus Therapeutics delivered strong results as product sales rose both domestically and abroad, while Fortrea Holdings provided operational services to biopharmaceutical companies with strong net bookings. |
| Oct 31 2025 | 2025 Q3 | AVPT, BE, CLF, GRND, PRIM, UEC | earnings, growth, Monetarypolicy, SmallCap, volatility | - | The commentary highlights small-cap investing driven by sustainable growth trends and expanding market breadth beyond mega-cap leadership. While stock selection detracted during the quarter, the strategy remains focused on balancing growth, quality, and valuation amid easing monetary policy and improving earnings visibility. Growth opportunities are expected to broaden as rate cuts and economic resilience support smaller companies. |
| QUARTER | THEMES | TAGS |
|---|---|---|
| 2025 Q4 |
AIAI has been integrated into RGA's research process through tools like NotebookLM, Gems in Gemini, and Claude Code. The firm views AI as a force multiplier for human judgment rather than a replacement, emphasizing the Kasparov Law principle. They believe the market narrative around AI displacement is swinging to unhelpful extremes, creating investment opportunities. |
Machine Learning Automation Software Productivity Innovation |
BiotechnologyHealthcare industry positioned for catch-up growth after several years of below-trend performance. Government spending expected to increase relative to feared cuts, with companies signaling improvement in revenue growth. Focus on 'picks & shovels' businesses serving the industry. |
Life Science Tools Pharmaceuticals CRO & CDMO Healthcare Research | |
Small CapsSmall caps getting strong start in 2026 supported by easing monetary conditions and constructive fiscal backdrop. Small caps more sensitive to economic cyclicality which is overdue for expansion. Expected to grow at better pace than large caps in 2026 after long period of underperformance. |
Value Growth Cyclical Monetary Policy Fiscal Policy | |
| 2025 Q3 |
Growth |
| Date | Pitch Type | Author | Ticker | Company | Industry | Sub Industry | Bull / Bear | Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 27, 2026 | Fund Letters | Sanne de Boer | BE | Bloom Energy Corporation | Industrials | Electrical Equipment | Bear | New York Stock Exchange | AI, data centers, Fuel cells, Power generation, valuation | Login |
| Jan 27, 2026 | Fund Letters | Sanne de Boer | HPP | Hudson Pacific Properties, Inc. | Real Estate | Office REITs | Bear | New York Stock Exchange | Leasing, Office, realestate, REITs, valuation | Login |
| Jan 27, 2026 | Fund Letters | Sanne de Boer | GEO | GEO Group, Inc. | Industrials | Security & Alarm Services | Bear | New York Stock Exchange | cashflow, Corrections, Government, restructuring, valuation | Login |
| Jan 27, 2026 | Fund Letters | Sanne de Boer | FLS | Flowserve Corporation | Industrials | Industrial Machinery | Bull | New York Stock Exchange | cashflow, earnings, Industrials, machinery, valuation | Login |
| Jan 27, 2026 | Fund Letters | Sanne de Boer | FOLD | Amicus Therapeutics, Inc. | Health Care | Biotechnology | Bull | NASDAQ | biotechnology, growth, healthcare, Quality, rare disease | Login |
| Jan 27, 2026 | Fund Letters | Sanne de Boer | FTRE | Fortrea Holdings Inc. | Health Care | Life Sciences Tools & Services | Bull | NASDAQ | Bookings, Cro, healthcare, lifesciences, recovery | Login |
| TICKER | COMMENTARY |
|---|---|
| BE | Bloom Energy is a provider of solid oxide fuel cells that play a critical role in delivering clean, reliable, always on power at scale. AI data centers require an enormous amount of power and one of the key challenges to date has been the inability of power grids to supply the necessary electricity to meet the constant and growing demands from AI workloads. Bloom's Energy Server fuel cells help address this issue, generating cost-efficient, reliable power onsite, converting fuels like natural gas, biogas and hydrogen into electricity without combustion. During the quarter, the company announced better than expected results with added optimism from a $5B partnership with Brookfield as the preferred onsite power provider for the company's global AI factories. |
| FLS | A non-benchmark position in Flowserve Corp. (FLS) had a positive impact on performance. FLS is an industrials stock that manufactures pumps, valves, and flow control systems for energy, chemicals, power, and industrial infrastructure. The ML model's rank it in the top 10% of the universe, driven by its valuation and volatility features. Within valuation, the operating cash flow to price, dividend yield and performance of value features are viewed positively in combination with its volatility features. During the quarter the stock rose after delivering strong 4Q25 results. |
| FOLD | An overweight position in Amicus Therapeutics, Inc. (FOLD) contributed to performance. Amicus is a commercial stage bio-technology company focused on rare disease therapies. The stock ranked in the top 25% of the universe, driven primarily by its quality features (research and development intensity, capital efficiency, and cash conversion cycle) relative to its small cap peers. During 4Q25, it delivered strong results as product sales rose both domestically and abroad. |
| FTRE | The overweight position to healthcare stock Fortrea Holdings Inc. (FTRE) had a positive impact on performance. FTRE ranked in the top 50% of the universe and had attractive factors embedded in the stock, which led to the overweight holding. Fortrea is a research organization that provides operational services to biopharmaceutical companies. During the quarter, the stock rose boosted by strong net bookings. |
| GEO | An overweight to the industrial stock GEO Group Inc. (GEO) detracted from performance. The company is ranked in the top 25% of the universe, driven primarily by its valuation features. Within the valuation composite, the earnings before interest, tax, depreciation and amortization (EBITDA), operating cash flow to price, and performance of value features drove the score up. GEO, which operates correctional and detention facilities for government agencies, fell during the quarter after reporting revenues below expectations and elevated administrative expenses tied to restructuring. |
| HPP | An overweight position in the real estate stock Hudson Pacific Properties, Inc. (HPP) detracted from performance. The company ranks in the top 15% of the universe, driven by the ML model's favorable view of its valuation and momentum of fundamental features. HPP is a West Coast office and studio real estate investment trust (REIT) serving technology and media tenants. The stock fell during the quarter as new leasing activity fell short of expectations. |
| Ticker | Put/Call | Amount Bought | Shares Bought | % Change | Weight % |
|---|---|---|---|---|---|
| No Recent Buys Data | |||||
| Ticker | Put/Call | Amount Sold | Shares Sold | % Change | Weight % | Status |
|---|---|---|---|---|---|---|
| No Recent Sells Data | ||||||
| Industry | Prev Quarter % | Current Quarter % | Change |
|---|---|---|---|
| No industry data available | |||